Cyclodextrin based nanosponges for pharmaceutical use: A review

Acta Pharmaceutica

Volumn 63, Issue 3, 2013, Pages 335-358

  Tejashri, Gursalkar ^a   Amrita, Bajaj ^b   Darshana, Jain ^a  

^a SNDT WOMEN S UNIVERSITY   (India)

^b SVKM S DR BHANUBEN NANAVATI COLLEGE OF PHARMACY   (India)

Author keywords

cyclodextrin; nanosponges; solubility enhancement

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CARBAMIC ACID; CARBONIC ACID; CYCLODEXTRIN; ESTER; ETHYL CELLULOSE; GAMMA CYCLODEXTRIN; NANOCARRIER; NANOMATERIAL; NANOSPONGE; POLYAMIDOAMINE; POLYLACTIC ACID; POLYMER; POLYVINYL ALCOHOL; SOLUBILIZER; TITANIUM DIOXIDE; UNCLASSIFIED DRUG;

CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HYDROPHILICITY; HYDROPHOBICITY; NANOTECHNOLOGY; REVIEW; SYNTHESIS; ZETA POTENTIAL;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; PARTICLE SIZE;

EID: 84887390835     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/acph-2013-0021     Document Type: Review

References (86)

1. L. Guo, G. Gao, X. Liu and F. Liu, Preparation and characterization of TiO2 nanosponge, Mater. Chem. Phys. 111 (2008) 322-325; DOI: 10.1186/1556-276X-6-551
2. D. Farrell, S. Limaye and S. Subramanian, Silicon Nanosponge Ppagess, U.S. Pat 0,251,561A1, 9 Nov 2006
3. V. Dakankov, M. Llyin, M. Tsyurupa, G. Timofeeva and L. Dubronina, From a dissolved polystyrene coil to intramolecularly hyper cross linked nanosponges, Macromolecules 29 (1998) 8398-8403; DOI: 10.1021/ma951673i
4. S. Swaminathan, L. Pastero, L. Serpe, F. Trotta, P. Vavia, D. Aquilano, M. Trotta, G. Zara and R. Cavalli, Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity, Eur. J. Pharm. Biopharm. 74 (2010) 193-201; DOI: 10.1016/j.ejpb.2009.11.003
5. F. Melani, P. Mura, M. Adamo, F. Maestrelli, P. Gratteri and C. Bonaccini, New docking CFF91 parameters specific for cyclodextrin inclusion complexes, Chem. Phys. Lett. 370 (2003) 280-292; DOI: 10.1016/S0009-2614(03) 00126-X
6. P. Couvreur and C. Vauthier, Nanotechnology: intelligent design to treat complex disease, Pharm. Res. 23 (2006) 1417-1450; DOI: 10.1007/s11095-006-0284-8
7. C. Zhang, N. Awasthi, M. A. Schwarz, S. Hinz and R. E. Schwarz, Superior antitumor activity of nanoppages albumin-bound paclitaxel in experimental gastric cancer, PLoS One. 8 (2013) e58037; DOI: 10.1371/journal.pone.0058037
8. Y. Fukumori and H. Ichikawa, Nanoppagess for cancer therapy and diagnosis, Adv. Powder Technol. 17 (2006) 1-28; DOI: 10.1163/156855206775123494
9. M. Morishita and N. Peppas, Is the oral route possible for peptide and protein drug delivery, Drug Discov. Today 11 (2006) 905-910; DOI: 10.1007/s11095-006-0284-8
10. H. Cohen, R. Levy, J. Gao, I. Fishbein, V. Kousaev, S. Sosnowski, S. Slomkowski and G. Golomb, Sustained delivery and expression of DNA encapsulated in polymeric nanoppagess, Gene Ther. 7 (2000) 1896-1905; DOI: 10.1038/sj.gt.3301318
11. L. Grislain, P. Couvreur, V. Lenaerts, M. Roland, D. Deprez-Decampeneere and P. Speiser, Pharmacokinetics and distribution of a biodegradable drug-carrier, Int. J. Pharm. 15 (1983) 335-345; DOI: 10.1016/0378-5173(83)90166- 7
12. L. Illum, S. S. Davis, C. G. Wilson, N. W. Thomas, M. Frier and J. G. Hardy, Blood clearance and organ deposition of intravenously administered colloidal ppagess, The effects of ppages size, nature and shape, Int. J. Pharm. 12 (1982) 135-146; DOI: 10.1016/0378-5173(82)90113-2
13. P. Couvreur, B. Kante, V. Lenaerts, V. Scailteur, M. Roland and P. Speiser, Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoppagess, J. Pharm. Sci. 69 (1980) 199-202; DOI: 10.1002/jps.2600690222
14. J. Kreuter, Nanoppagess, in Encyclopedia of Pharmaceutical Technology (Ed. J. Swarbrick and J. C. Boylan), Marcel Dekker In., New York 1994, pp.165-190
15. J. Xing, D. Zhang and T. Tan, Studies on the oridonin-loaded poly(D, L-lactic acid) nanoppagess in vitro and in vivo, Int. J. Biol. Macromol. 40 (2007) 153-158; DOI: 10.1016/j.ijbiomac.2006.07.001
16. E. Garcia-Garcia, K. Andrieux, S. Gil and P. Couvreur, Colloidal carriers and blood-brain barrier (BBB) translocation: Away to deliver drugs to the brain, Int. J. Pharm. 298 (2005) 274-292; DOI: 10.1016/j.ijpharm.2005.03.031
17. S. Subramanian, A. Singireddy, K. Krishnamoorthy and M. Rajappan, Nanosponges: ANovel Class of Drug Delivery System - Review, J. Pharm. Pharmac. Sci. 15 (2012) 103-111
18. A. Nokhodchi, M. Jelvehgari, M. Reza Siahi and M. Reza Mozafar, Factors affecting the morphology of benzoyl peroxide microsponges, Micron 38 (2007) 834-840, DOI: 10.1016/j.micron. 2007.06.012
19. F. Trotta and R. Cavalli, Characterization and application of new hyper-cross-linked cyclodextrins, Compos. Interfaces 16 (2009) 39-48, DOI: 10.1163/156855408X379388
20. F. Trotta, R. Cavalli, V. Tumiatti, O. Zerbinati, C. Roggero and R. Vallero, Ultrasound Assisted Synthesis of Cyclodextrin Based Nanosponges, EP Pat 1786841A1, 23May, 2007
21. S. Eki, T. Lei, L. Jingquan, J. Zhongfan, B. Cyrille and P. D. Thomas, Biodegradable star polymers functionalized with b-cyclodextrin inclusion complexes, Biomacromolecules, 10 (2009) 2699-2707; DOI: 10.1021/bm900646g
22. S. Swaminathan, R. Cavalli, F. Trotta, P. Ferruti, E. Ranucci, I. Gerges, A. Manfredi, D. Marinotto and P. Vavia, In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of b-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem. 68 (2010) 183-191; DOI: 10.1007/s10847-010-9765-9
23. A. Vyas, S. Saraf and S. Saraf, Cyclodextrin based novel drug delivery systems, J. Incl. Phenom. Macrocycl. Chem. 62 (2008) 23-42; DOI: 10.1007/s10847-008-9456-y
24. T. Girek and W. Ciesielski, Polymerization of b-cyclodextrin with maleic anhydride along with thermogravimetric study of polymers, J. Incl. Phenom. Macrocycl. Chem. (2010) 1-7; DOI: 10. 1007/s10847-010-9778-4
25. D. Li and M. Ma, Nanosponges: From inclusion chemistry to water purifying technology, Chem. Sci. Technol. (1999) 26-28
26. C. Rajeswari, A. Alka, A. Javed and R. Khar, Cyclodextrins in drug delivery: an update review, AAPS PharmSciTech. 6 (2005) E329-E357; DOI: 10.1208/pt060243
27. A. Modi and P. Tayade, Comparative solubility enhancement profile of valdecoxib with different solubilization approaches, Ind. J. Pharm. Sci. 69 (2007) 427-430; DOI: 10.4103/0250-474X. 33156
28. R. Cavalli, F. Trotta and W. Tumiatti, Cyclodextrin-based nanosponges for drug delivery, J. Incl. Phenom. Macrocycl. Chem. 56 (2006) 209-213; DOI: 10.1007/s10847-006-9085-2
29. F. Trotta, V. Tumiatti, R. Cavalli, C. Roggero, B. Mognetti and G. Berta, Cyclodextrin-based Nanosponges as a Vehicle for Antitumoral Drugs, WO 2009/003656 A1; 2009
30. F. Trotta and T. Wander, Cross-linked Polymers Based on Cyclodextrins for Removing Polluting Agents, WO 2003/085002, US20050154198 A1, 14 July. 2005
31. S. Swaminathan, P. Vavia, F. Trotta and S. Torne, Formulation of beta-cyclodextrin based nanosponges of Itraconazole, J. Incl. Phenom. Macrocycl. Chem. 57 (2007) 89-94; DOI: 10.1007/s10847-006-9216-9
32. A. Mele, F. Castiglione, L. Malpezzi, F. Ganazzoli, G. Raffaini, F. Trotta, B. Rossi, A. Fontana and G. Giunchi, HR MAS NMR, powder XRD and Raman spectroscopy study of inclusion phenomena in b-CD nanosponges, J. Incl. Phenom. Macrocycl. Chem. 69 (2011) 403-409; DOI: 10.1007/ s10847-010-9772-x
33. S. Swaminathan, P. Vavia, F. Trotta, R. Cavalli, P. Ferruti, E. Ranucci and I. Gerges, Release modulation and conformational stabilization of a model protein by use of swellable nanosponges of b-cyclodextrin, First European Cyclodextrin Conference, Aalborg, Denmark 2009
34. S. Torne, K. Ansari, P. Vavia, F. Trotta and R. Cavalli, Enhanced oral bioavailability after administration of paclitaxel-loaded nanosponges, Drug Deliv. 17 (2010) 419-425; DOI: 10.3109/ 10717541003777233
35. K. Ansari, P. Vavia, F. Trotta and R. Cavalli, Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study, AAPS Pharm SciTech, 12 (2011) 279-286; DOI: 10.1208/s12249-011-9584-3
36. E. Patel and R. Oswal, Nanosponge and micro sponges: Anovel drug delivery system, Int. J. Res. Pharm. Chem. 2 (2012) 237-244
37. T. Loftsson and M. Brewster, Pharmaceutical applications of cyclodextrins: drug solubilization and stabilization, J. Pharm. Pharmacol. 85 (1996) 1017-1025; DOI: 10.1021/js950534b
38. A. Radi and S. Eissa, Electrochemical study of indapamide and its complexation with b-cyclodextrin, J. Incl. Phenom. Macrocycl. Chem. 71 (2011) 95-102; DOI: 10.1007/s10847-010.9906-1
39. H. Bricout, F. Hapiot, A. Ponchel, E. Monflier and S. Tilloy, Chemically modified cyclodextrins: an attractive class of supramolecular hosts for the development of aqueous biphasic catalytic processes, Sustainability 1 (2009) 924-945; DOI: 10.3390/su1040924
40. H. Dodziuk, Molecules with Holes - Cyclodextrins, in Cyclodextrins and Their Complexes (Ed. H. Dodziuk), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 2006, pp. 1-30
41. D. Li and M. Ma, Nanosponges for water purification, Clean Prod. Process. 2 (2000) 112-16; DOI: 10.1007/s100980000061
42. E. Bilensoy and A. Atilla, Cyclodextrin-based Nanomaterials in Pharmaceutical Field, in Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing, John Wiley & Sons Inc. Publishers 2010; DOI: 10.1002/9780470259818.ch31
43. R. Lala, A. Thorat and C. Gargote, Current trends in b-cyclodextrin based drug delivery systems, Int. J. Res. Ayur. Pharm, 2 (2011) 1520-1526
44. B. Mamba, R. Krause, T. Malefetse and S. Sithhole, Cyclodextrin nanosponges in the removal of organic matter to produce water for power generation, Water SA, 34 (2008) 657-660
45. B. Mamba, R. Krause, T. Malefetse, S. Mhlanga, S. Sithhole, K. Salipira and E. Nxumalo, Removal of geosmin and 2-methylisoborneol (2-MIB) in water from Zuikerbosch water treatment plant (Rand Water) using b-cyclodextrin polyurethane, Water SA, 32 (2007) 223-228
46. S. Tang, L. Kong, J. Ou, Y. Liu, X. Li and H. Zou, Application of cross-linked b-cyclodextrin polymer for adsorption of aromatic amino acid, J. Mol. Recogn. Macrocyclic Chem. 19 (2006) 39-48; DOI: 10.1002/jmr.756
47. F. Trotta, R. Cavalli, S. Swaminathan, C. Sarzanini and P. Vavia, Novel functionalized nanosponges: synthesis, characterization. Safety assessment, cytotoxicity testing and interaction studies. Proceedings of the 14th International Cyclodextrin Symposium, Kyoto 2008, pp. 338-342
48. G. Yurtdas, M. Demirel and L. Genc, Inclusion complexes of fluconazole with b-cyclodextrin: physicochemical characterization and in vitro evaluation of its formulation, J. Incl. Phenom. Macrocycl. Chem. 70 (2011) 429-435; DOI: 10.1007/s10847-010-9908-z
49. A. Rasheed, Cyclodextrins as drug carrier molecule: Areview, Sci. Pharmac. 76 (2008) 567-598; DOI: 10.3797/scipharm.0808-05
50. P. Sinko, Martin's Physical Pharmacy and Pharmaceutical Sciences, 5th ed., Lippincott Williams & Williams Publishers, Philadelphia 2006, p.466
51. T. Govender, S. Stolnik, M. Garnett, L. Illum and S. Davis, PLGA nanoppagess prepared by nanoprecipitation: drug loading and release studies of a water soluble drug, J. Control. Release 57 (1999) 171-185; DOI: 10.1016/S0168-3659(98)00116-3
52. S. Galindo-Rodriguez, E. Allémann, H. Fessi and E. Doelker, Physicochemical parameters associated with nanoppages formation in the salting-out, emulsification-diffusion and nanoprecipitation methods, Pharm. Res. 21 (2004) 1428-1439; DOI: 10.1023/B:PHAM.0000036917.75634.be
53. M. Leroueil-Le Verger, L. Fluckiger, Y. Kim, M. Hoffman and P. Maincent, Preparation and characterization of nanoppagess containing an antihypertensive agent, Eur. J. Pharm. Biopharm. 46 (1998) 137-143; DOI: 10.1016/S0939-6411(98) 00015-0
54. N. Santos-Magalhães, H. Fessi, F. Puisieux, S. Benita and M. Seiller, An in-vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride, J. Microencapsul. 12 (1995) 195-205; DOI: 10.3109/02652049509015290
55. A. Layre, R. Gref, J. Richard, D. Requier, H. Chacun, M. Appel, A. Domb and P. Couvreur, Nanoencapsulation of a crystalline drug, Int. J. Pharm. 298 (2005) 323-327; DOI: 10.1016/j. ijpharm.2005.02.039
56. D. Lemoine, C. Francois, F. Kedzierewicz, V. Preat, M. Hoffman and P. Maincent, Stability study of nanoppagess of poly(b-caprolactone), poly(D, L-lactide) and poly(D, L-lactideco-glycolide), Biomaterials 17 (1996) 2191-2197. DOI: 10.1016/0142-9612(96)00049-X
57. Y. Jeong, Y. Shim, C. Kim, G. Lim, K. Choi and C. Yoon, Effect of cryoprotectants on the reconstitution properties of surfactant-free nanoppagess of poly (D,L-lactide-co-glycolide), J. Microencapsul. 22 (2005) 593-601; DOI: 10.1080/02652040500162659
58. H. Redhead, S. Davis and L. Illum, Drug delivery in poly(lactide-co- glycolide) nanoppagess surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation, J. Control. Release, 70 (2001) 353-363; DOI: 10.1016/S0168-3659(00)00367-9
59. M. Bivas-Benita, S. Romeijn, H. Junginger and G. Borchard, PLGA-PEI nanoppagess for gene delivery to pulmonary epithelium, Eur. J. Pharm. Biopharm. 58 (2004) 1-6; DOI: 10.1016/j.ejpb. 2004.03.008
60. R. Pecora, Dynamic light scattering measurement of nanometer ppagess in liquids, J. Nanoppages Res. 2 (2000) 123-131; DOI: 10.1023/A:1010067107182
61. M. Santander-Ortega, A. Jódar-Reyes, N. Csabac, D. Bastos-González and J. Ortega-Vinuesa, Colloidal stability of Pluronic F68-coated PLGA nanoppagess: Avariety of stabilisation mechanisms, J. Colloid. Interf. Sci. 302 (2006) 522-529; DOI: 10.1016/j.jcis.2006.07.031
62. Y. Ishikawa, Y. Katoh and H. Ohshima, Colloidal stability of aqueous polymeric dispersions: effect of pH and salt concentration, Colloid Surf. B 42 (2005) 53-58; DOI: 10.1016/j.colsurfb.2005. 01.006
63. J. Shar, T. Obey and T. Cosgrove, Adsorption studies of polyether's- Part1: Adsorption onto hydrophobic surfaces, Colloid Surf A: Physicochemical and Engineering Aspects 136 (1998) 21-33, DOI: 10.1016/S0927-7757(97)00182-9
64. E. Leo, B. Brina, F. Forni and M. Vandelli, In vitro evaluation of PLA nanoppagess containing a lipophilic drug in water-soluble or insoluble form, Int. J. Pharm. 278 (2004) 133-141, DOI: 10. 1016/j.ijpharm.2004.03.002
65. U. Bilati, E. Allemann and E. Doelker, Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoppagess, Eur. J. Pharm. Sci. 24 (2005) 67-75; DOI: 10.1016/j.ejps.2004.09.011
66. M. Bivas-Benita, S. Romeijn, H. Junginger and G. Borchard, PLGA-PEI nanoppagess for gene delivery to pulmonary epithelium, Eur. J. Pharm. Biopharm. 58 (2004) 1-6; DOI: 10.1016/j.ejpb. 2004.03.008
67. H. Fessi, F. Puisieux, J. Devissaguet, N. Ammoury and S. Benita, Nanocapsule formation by interfacial polymer deposition following solvent displacement, Int. J. Pharm. 55 (1989) R1-R4; DOI: 10.1016/0378-5173(89)90281-0
68. M. Chorny, I. Fishbein, H. D. Danenberg and G. Golomb, Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics, J. Control. Release 83 (2002) 389-400; DOI: 10.1016/S0168-3659(02)00211-0
69. V. Mosqueira, P. Legrand, H. Pinto-Alphandary, F. Puisieux and G. Barratt, Poly (D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties, J. Pharm. Sci. 89 (2000) 614-626; DOI: 10.1002/(SICI) 1520-6017(200005)89:5<614::AID-JPS7>3.0.CO;2-7
70. J. Ren, H. Hong, J. Song and T. Ren, Ppages size and distribution of biodegradable poly-D,L-lactide-co-poly(ethylene glycol) block polymer nanoppagess prepared by nanoprecipitation, J. Appl. Polym. Sci. 98 (2005) 1884-1890; DOI: 10.1002/app.22070
71. M. Teixeira, M. Alonso, M. Pinto and C. Barbosa, Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3methoxyxanthone, Eur. J. Pharm. Biopharm. 59 (2005) 491-500; DOI: 10.1016/j.ejpb.2004.09.002
72. M. Tobìo, R. Gref, A. Sanchez, R. Langer and M. Alonso, Stealth PLA-PEG nanoppagess as protein carriers for nasal administration, Pharm. Res. 15 (1998) 276-279; DOI: 10.1023/A:1011922819926
73. H. Brittain, D. Bogdanowich, J. DeVincentis, G. Lewen and A.Newman, Physical characterization of pharmaceutical solids, Pharm. Res. 8 (1991) 963-973. DOI: 10.1023/A:1015888520352
74. M. Hombreiro-Perez, J. Siepmann, C. Zinutti, A. Lamprecht, N. Ubrich, M. Hoffman, R. Bodmeier and P. Maincent, Non-degradable microppagess containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling, J. Control. Release 88 (2003) 413-428; DOI: 10.1016/S0168-3659(03)00030-0
75. M. Guyot and F. Fawaz, Nifedipine loaded-polymeric microspheres: preparation and physical characteristics, Int. J. Pharm. 175 (1998) 61-74; DOI: 10.1016/S0378-5173(98)00253-1
76. Y. Jeong, Y. Shim, K. Song, Y. Park, H. Ryu and J. Nah, Testosterone encapsulated surfactant-free nanoppagess of poly(D,L-lactide-co-glycolide): preparation and release behavior, Bull. Korean Chem. Soc. 23 (2002) 1579-1584
77. R. Suryanarayanan, X-Ray Powder Diffractometry, in Physical Characterization of Pharmaceutical Solids, Vol. 70 (Ed. H. G. Brittain), Marcel Dekker Inc., New York 1995, pp.187-221
78. J. Alongi, M. Skovi, A. Frache and F. Trotta, Novel flame retardants containing cyclodextrin nanosponges and phosphorus compounds to enhance EVA combustion properties, Polym. Degrad. Stabil. 95 (2010) 2093-2100; DOI: 10.1016/j.polymdegradstab.2010.06.030
79. G. Gilardi, F. Trotta, R. Cavalli, P. Ferruti, E. Ranucci, G. Di Nardo, C. Roggero and V. Tumiatti, Cyclodextrin Nanosponges as Carrier for Biocatalysts, and in the Delivery and Release of Enzymes, Proteins, Vaccines and Antibodies, WO2009149883 A1, 17 Dec.2009
80. S. Renuka, B. W. Roderick and P. Kamla, Evaluation of the kinetics and mechanism of drug release from Econazole Nitrate nanosponge loaded carbopol hydrogel, Ind. J. Pharm. Edu. Res. 45 (2011) 25-31
81. S. Renuka and P. Kamla, Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation, Pharm. Dev. Technol. 16 (2011) 367-376; DOI: 10.3109/10837451003739289
82. S. Baboota, R. Khanna, S. Agarwal, J. Ali and A. Ahuja, Cyclodextrins in Drug Delivery Systems: An update, Available from Pharma. info. net., 2003, accessed on 13/01/2011
83. V. N. Wong, G. Fernando, A. R. Wagner, J. Zhang, G. R. Kinsel, S. Zauscher and D. J. Dyer, Separation of peptides with polyionic nanosponges for MALDIMS analysis, Langmuir 25 (2009) 1459-1465; DOI: 10.1021/la802723r
84. A. Jenny, P. Merima, F. Alberto and T. Francesco, Role of b-cyclodextrin nanosponges in polypropylene photooxidation, Carbohyd. Polym. 86 (2011) 127-135; DOI: 10.1016/j.carbpol.2011.04. 022
85. K. William, S. Benjamin and H. Eva, Synthesis and Characterization of Nanosponges for Drug Delivery and Cancer Treatment, www.Vanderbilt.edu, accessed on 20.12.2011
86. L. Wenting, Y. Cheng, N. Masaki, F. Gaku, M. Tadashi, M. Andrea, C. Franca, C. Fabrizio, T. Francesco and I. Yoshihisa, Cyclodextrin nanosponge-sensitized enantiodifferentiating photoisomerization of cyclooctene and 1,3-cyclooctadiene, Beilstein J. Org. Chem. 8 (2012) 1305-1311; DOI: 10.3762/bjoc.8.149